CPHA Canvax

"On June 18, 2022, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the use of the Moderna COVID-19 vaccine for children aged 6 months–5 years and for the Pfizer-BioNTech COVID-19 vaccine for children aged 6 months–4 years in the United States for prevention of COVID-19." - Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022

Additional Authors: Elisha Hall, Ruth Link-Gelles, Monica Godfrey, Kate R. Woodworth, Tara C. Anderson, Amy B. Rubis, Edwin Shanley III, Jefferson M. Jones, Rebecca L. Morgan, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew Daley, Sarah Meyer, Sara E. Oliver

Rating See Comments Ratings


Vaccine Safety and Development,Vaccine Safety,Vaccine Safety,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Program Planning and Delivery,Program Delivery and Evaluation,Clinics Vaccine Safety and Development
Vaccine Safety
Vaccine Safety
Monitoring and Surveillance
Outbreaks and Pandemics
Program Planning and Delivery
Program Delivery and Evaluation


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.